Description
A selective inhibitor of PDE4 (IC50 = 1.27 μM for PDE4 versus >100 μM for PDE1, PDE2, PDE3, and PDE5); inhibits eosinophil superoxide production (IC50 induced TNFα release from monocytes ,(IC50 = 0.22 μM); significantly reduces antigen-induced airway inflammation in atopic guinea pigs, monkeys, and mice
Formal name: 5-[3-[(1S,2S,4R)-bicyclo[2.2.1]hept-2-yloxy]-methoxyphenyl]tetrahydro-2-(1H)-pyrimidinone
Synonyms:
Molecular weight: 316.4
CAS: 135637-46-6
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|Phosphodiesterases||Research Area|Cell Biology|Cell Signaling|cAMP Signaling||Research Area|Immunology & Inflammation|Adaptive Immunity||Research Area|Immunology & Inflammation|Allergy||Research Area|Immunology & Inflammation|Innate Immunity